go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

SIMStation GmbH

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Topic
Other
telemedicine and e-health
software for medicine
Details

Exias Medical GmbH

Organization type
RDM medtech
Region
Styria
Cluster
Human.technology Styria
Details

Baxter Medical Products GmbH

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Topic
biological-derived devices
single-use devices
resuable devices
Details

F. Schmidl

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Topic
assistive products for persons with disability
Details

Contact



Contact: